Huntington’s chorea, now usually called Huntington’s disease, is an inherited brain disorder that progressively destroys nerve cells in the brain. It causes involuntary movements (the “chorea” the name refers to), psychiatric changes, and a steady decline in thinking ability. The disease affects roughly 5 people per 100,000 worldwide, appears most often between ages 30 and 50, and gradually worsens over 10 to 20 years after symptoms first emerge.
Why It’s Called “Chorea”
The word chorea comes from the Greek word for dance. It describes the involuntary, jerking, writhing movements that are one of the disease’s hallmarks. These movements can affect the arms, legs, face, and tongue, and they’re often the first visible sign that something is wrong. Early on, chorea may look like fidgeting or restlessness. Over time, the movements become more pronounced and harder to mask.
Chorea isn’t the only motor symptom, though. As the disease progresses, people often develop muscle rigidity, trouble with balance and walking, difficulty swallowing, and slowed or unusual eye movements. In later stages, the involuntary movements may actually decrease while stiffness and difficulty with voluntary movement take over. This shift is one reason the older name “Huntington’s chorea” fell out of use: the disease involves far more than just the dance-like movements.
The Genetic Cause
Huntington’s disease is caused by a mutation in a single gene called HTT, which provides instructions for making a protein called huntingtin. Inside this gene, a short DNA sequence (CAG) repeats itself in a row. Everyone has some CAG repeats in this gene, but the number determines whether the disease develops.
- Fewer than 27 repeats: Normal. No risk of Huntington’s.
- 27 to 35 repeats: An intermediate range. The person won’t develop the disease, but the repeat count can expand when passed to children, potentially crossing into the danger zone in the next generation.
- 36 to 39 repeats: Reduced penetrance. Some people in this range develop the disease, others don’t.
- 40 or more repeats: Full penetrance. The disease will develop if the person lives long enough.
Huntington’s follows an autosomal dominant inheritance pattern, meaning a child of someone carrying the mutation has a 50% chance of inheriting it. There is no skipping generations in the way some genetic conditions can hide. If you don’t inherit the expanded gene, you cannot pass it on.
What Happens in the Brain
The mutant huntingtin protein is toxic to brain cells, and the damage hits one area hardest: the striatum, a structure deep in the brain that helps coordinate movement, regulate mood, and support decision-making. The striatum’s projection neurons, the cells that send signals outward to other brain regions, are the most vulnerable. Their progressive loss leads to severe shrinkage of the striatum and drives the motor symptoms that define the disease.
The damage doesn’t stay confined to one region. The deep layers of the cerebral cortex, which send signals into the striatum, also shrink and lose neurons as the disease advances. The thalamus suffers as well. One part of the thalamus (the centromedian/parafascicular complex) can lose roughly 50% of its neurons and 25% of its volume in advanced disease. Even the substantia nigra, a structure involved in dopamine production, shows measurable shrinkage. This widespread, cascading damage explains why Huntington’s affects so many different functions: movement, thinking, mood, and eventually basic life-sustaining abilities like swallowing and breathing.
Psychiatric and Cognitive Symptoms
Movement problems tend to get the most attention, but for many people with Huntington’s, the psychiatric and cognitive symptoms are just as disabling, and they often appear first. Between 73% and 98% of people with Huntington’s will experience a major psychiatric disorder or significant psychiatric symptoms at some point during the disease.
Depression is the most common, diagnosed in roughly half of all patients. It frequently appears before any motor symptoms, sometimes years before a formal diagnosis. Irritability, apathy, and anxiety are also extremely common. Some people develop obsessive or compulsive behaviors, and a smaller number experience psychotic symptoms like hallucinations or delusions. These psychiatric changes are caused directly by the brain degeneration, not simply by the emotional burden of living with the disease.
Cognitive decline follows its own pattern. Early on, people notice difficulty with planning, organizing, and multitasking. Reaction times slow. Thinking becomes less flexible. Over the years, these deficits deepen into a broader loss of cognitive function, though it typically doesn’t look like the memory-centered decline seen in Alzheimer’s disease. Instead, it centers on what neurologists call executive function: the ability to manage, prioritize, and shift between tasks.
Juvenile-Onset Huntington’s
About 5% to 10% of cases begin before age 20, a form known as juvenile Huntington’s disease. It tends to occur when the CAG repeat count is especially high, often above 55 or 60, and the expanded gene is usually inherited from the father. The symptoms look quite different from adult-onset disease. Chorea is less prominent. Instead, children and teenagers often show rigidity, seizures, rapid cognitive decline, and difficulty with schoolwork. The disease also tends to progress faster than the adult form.
Genetic Testing and Diagnosis
Diagnosis in someone already showing symptoms typically involves a neurological exam combined with a genetic blood test that counts the number of CAG repeats in the HTT gene. The test is definitive: it can confirm or rule out the disease with certainty.
For people at risk but not yet showing symptoms, predictive genetic testing is available, generally from age 18 onward. Because there is no cure and the result is life-altering, genetic counseling is a required part of the process. This usually involves multiple appointments spread over weeks or months, during which a counselor assesses readiness and discusses the implications of a positive or negative result. Not everyone who begins the process chooses to receive their result, and that’s considered a valid outcome. The testing protocol exists specifically because of the psychological weight of learning you carry a gene for an incurable, fatal disease.
How Chorea Is Managed
There is no treatment that slows or stops the underlying brain degeneration in Huntington’s disease. Current management focuses on reducing symptoms and preserving quality of life for as long as possible.
For chorea specifically, medications that reduce dopamine activity in the brain can quiet the involuntary movements. The first drug approved in the U.S. for Huntington’s-related chorea works by depleting dopamine from nerve cells, and it remains a standard option. A newer formulation with a similar mechanism was later approved as well. These medications can meaningfully reduce chorea, but they carry side effects including drowsiness, depression, and difficulty swallowing, so the decision to use them involves weighing how much the movements interfere with daily life against those risks.
Antipsychotic medications are sometimes used as an alternative, particularly when psychiatric symptoms like irritability or psychosis are also present. For depression, standard antidepressants are commonly prescribed and can be effective. Physical therapy helps maintain mobility and balance. Speech therapy addresses swallowing difficulty and communication problems. Occupational therapy can help people adapt their homes and routines as abilities change.
As the disease advances, care becomes more intensive. People in later stages typically need full-time assistance with eating, dressing, and mobility. The most common causes of death are complications from immobility, such as pneumonia, or from difficulty swallowing.
The 50/50 Dilemma for Families
One of the most difficult aspects of Huntington’s disease is the genetic math. Each child of an affected parent lives with a coin-flip chance of having inherited the mutation. This uncertainty often shapes families for decades. Some at-risk individuals choose predictive testing to plan their futures. Others prefer not to know. Family planning is a major consideration: preimplantation genetic testing during IVF can ensure the expanded gene is not passed to the next generation, offering a path to having biological children without transmitting the disease.